Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer

P Kovacic1, J D Jacintho

  • 1Department of Chemistry, San Diego State University, San Diego, CA92182-1030, USA. jgenoves@sundown.sdsu.edu

Insights

Oxidative stress (OS) plays a key role in cancer development, driven by reactive oxygen species (ROS) generated through electron transfer (ET) processes. Understanding this ET-OS link aids in cancer prevention strategies.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Carcinogen action mechanisms have been debated for decades.
  • Oxidative stress (OS) is increasingly recognized for its role in various cancer aspects.
  • Reactive oxygen species (ROS) are implicated in cancer initiation and progression.

Purpose of the Study:

  • To review evidence linking oxidative stress to carcinogenesis.
  • To explore the role of electron transfer (ET) in ROS generation by carcinogens.
  • To present OS as a unifying theme in cancer research.

Main Methods:

  • Literature review of evidence implicating OS in oncology.
  • Analysis of ROS generation mechanisms via electron transfer (ET) groups.
  • Examination of carcinogen functionalities and their relation to ROS.

Main Results:

  • Diverse carcinogens generate ROS through ET mechanisms (e.g., quinones, metal complexes).
  • ROS contribute to DNA damage, mutations, and oncogene activation.
  • OS is implicated across various cancer stages, aging, and related illnesses.

Conclusions:

  • The electron transfer-oxidative stress (ET-OS) model provides a unifying framework for understanding carcinogenesis.
  • This framework aids in comprehending cancer initiation and developing prevention strategies.
  • The ET-OS concept extends to understanding drug actions, toxins, and hormonal effects.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...